Literature DB >> 3347344

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis.

P L Andres1, L J Finison, T Conlon, L M Thibodeau, T L Munsat.   

Abstract

The Tufts Quantitative Neuromuscular Exam (TQNE) consists of 28 items that were designed to measure voluntary motor deficit in amyotrophic lateral sclerosis (ALS) and related diseases. Individual raw data were converted to Z scores for standardization and then grouped into five megascores with statistical and clinical relevance. The derived megascores were Mega 1, pulmonary function; Mega 2, bulbar function; Mega 3, timed hand activities; Mega 4, isometric arm strength; and Mega 5, isometric leg strength. Megascores should enhance the usefulness of testing in therapeutic trials and in analyzing the natural history of ALS and related diseases.

Entities:  

Mesh:

Year:  1988        PMID: 3347344     DOI: 10.1212/wnl.38.3.405

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.

Authors:  Seward B Rutkove; Hui Zhang; David A Schoenfeld; Elizabeth M Raynor; Jeremy M Shefner; Merit E Cudkowicz; Anne B Chin; Ronald Aaron; Carl A Shiffman
Journal:  Clin Neurophysiol       Date:  2007-09-25       Impact factor: 3.708

Review 3.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

Review 4.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system.

Authors:  Jeremy M Shefner; Seward B Rutkove; James B Caress; Michael Benatar; William S David; Michael S Cartwright; Eric A Macklin; Jose L Bohorquez
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-09-28       Impact factor: 4.092

Review 6.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 7.  Strength Testing in Motor Neuron Diseases.

Authors:  Jeremy M Shefner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

8.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

9.  Multi-domain predictors of oppositional defiant disorder symptoms in preschool children: cross-informant differences.

Authors:  John V Lavigne; Katharine P Dahl; Karen R Gouze; Susan A LeBailly; Joyce Hopkins
Journal:  Child Psychiatry Hum Dev       Date:  2015-04

Review 10.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.